These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease. Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973 [TBL] [Abstract][Full Text] [Related]
24. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. Halliday GM; Macdonald V; Henderson JM Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651 [TBL] [Abstract][Full Text] [Related]
25. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy. Boelmans K; Holst B; Hackius M; Finsterbusch J; Gerloff C; Fiehler J; Münchau A Mov Disord; 2012 Mar; 27(3):421-7. PubMed ID: 22290788 [TBL] [Abstract][Full Text] [Related]
26. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism. Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684 [TBL] [Abstract][Full Text] [Related]
27. Selective frontal neurodegeneration of the inferior fronto-occipital fasciculus in progressive supranuclear palsy (PSP) demonstrated by diffusion tensor tractography. Kvickström P; Eriksson B; van Westen D; Lätt J; Elfgren C; Nilsson C BMC Neurol; 2011 Jan; 11():13. PubMed ID: 21269463 [TBL] [Abstract][Full Text] [Related]
28. Morphometric analysis of thalamic volume in progressive supranuclear palsy: In vivo evidence of regionally specific bilateral thalamic atrophy. Power BD; Jakabek D; Hunter-Dickson M; Wilkes FA; van Westen D; Santillo AF; Walterfang M; Velakoulis D; Nilsson C; Looi JCL Psychiatry Res Neuroimaging; 2017 Jul; 265():65-71. PubMed ID: 28550719 [TBL] [Abstract][Full Text] [Related]
29. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Walter U; Dressler D; Wolters A; Probst T; Grossmann A; Benecke R Neurology; 2004 Aug; 63(3):504-9. PubMed ID: 15304582 [TBL] [Abstract][Full Text] [Related]
30. Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism. Srulijes K; Reimold M; Liscic RM; Bauer S; Dietzel E; Liepelt-Scarfone I; Berg D; Maetzler W Mov Disord; 2012 Jan; 27(1):151-5. PubMed ID: 22359740 [TBL] [Abstract][Full Text] [Related]
31. 3-D analysis of cortical morphometry in differential diagnosis of Parkinson's plus syndromes: mapping frontal lobe cortical atrophy in progressive supranuclear palsy patients. Tosun D; Duchesne S; Rolland Y; Toga AW; Vérin M; Barillot C Med Image Comput Comput Assist Interv; 2007; 10(Pt 2):891-9. PubMed ID: 18044653 [TBL] [Abstract][Full Text] [Related]
32. MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome. Upadhyay N; Suppa A; Piattella MC; Bologna M; Di Stasio F; Formica A; Tona F; Colosimo C; Berardelli A; Pantano P J Neurol; 2016 Oct; 263(10):2022-31. PubMed ID: 27411806 [TBL] [Abstract][Full Text] [Related]
40. Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease. Surova Y; Lampinen B; Nilsson M; Lätt J; Hall S; Widner H; ; van Westen D; Hansson O PLoS One; 2016; 11(6):e0157755. PubMed ID: 27362763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]